大都會人壽 (MetLife) 第二季財報優於預期，有機成長亮眼強化買進評級 (NYSE:MET)
· seekingalpha.com
由於基本面強勁、有機成長及股息具備韌性，大都會人壽股票維持「買進」評級。點擊此處查看 MET 至 2026 年的估值上漲空間與關鍵風險。
Albert Anthony is the pen name of a business author on Amazon and his newest book is "How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Tec...